Singapore markets closed

IN8bio, Inc. (INAB)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.0097-0.0103 (-1.01%)
As of 10:36AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
12,827
16,827
14,062
7,347
5,378
Selling general and administrative
13,745
13,510
14,459
7,306
3,179
Total operating expenses
26,572
30,337
28,521
14,653
8,557
Operating income or loss
-26,572
-30,337
-28,521
-14,653
-8,557
Total other income/expenses net
330
330
-
-
-
Income before tax
-26,572
-30,007
-28,521
-14,653
-8,557
Income from continuing operations
-26,572
-30,007
-28,521
-14,653
-8,557
Net income
-26,572
-30,007
-28,521
-14,653
-8,557
Net income available to common shareholders
-26,572
-30,007
-28,521
-14,653
-10,340
Basic EPS
-1.10
-1.00
-1.36
-1.47
-0.53
Diluted EPS
-1.10
-1.00
-1.36
-1.47
-0.53
Basic average shares
27,344
29,865
20,968
9,970
19,431
Diluted average shares
27,344
29,865
20,968
9,970
19,431